Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Bexotegrast

🥰Excellent
Catalog No. T39933Cas No. 2376257-44-0
Alias PLN-74809

Bexotegrast (PLN-74809) is an orally active and potent inhibitor of αvβ6 and αvβ1 integrins with antifibrotic effects, inhibiting αvβ6 and αvβ1-induced activation of TGF-β. It is applicable for studies of idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP).

Bexotegrast

Bexotegrast

🥰Excellent
Purity: 99.53%
Catalog No. T39933Alias PLN-74809Cas No. 2376257-44-0
Bexotegrast (PLN-74809) is an orally active and potent inhibitor of αvβ6 and αvβ1 integrins with antifibrotic effects, inhibiting αvβ6 and αvβ1-induced activation of TGF-β. It is applicable for studies of idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP).
Pack SizePriceAvailabilityQuantity
1 mg$125In Stock
5 mg$457In Stock
10 mg$789In Stock
25 mg$1,370In Stock
50 mg$2,324In Stock
100 mg$3,818In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Bexotegrast"

Select Batch
Purity:99.53%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Bexotegrast (PLN-74809) is an orally active and potent inhibitor of αvβ6 and αvβ1 integrins with antifibrotic effects, inhibiting αvβ6 and αvβ1-induced activation of TGF-β. It is applicable for studies of idiopathic pulmonary fibrosis (IPF) and non-specific interstitial pneumonia (NSIP).
Targets&IC50
αvβ6:5.7 nM (Kd), αvβ1:3.4 nM (Kd)
In vitro
Bexotegrast (PLN-74809; 1.82 µM; incubation for 7 days) inhibits lung collagen deposition and Smad3 phosphorylation in a dose-dependent manner[2].
In vivo
Bexotegrast(PLN-74809;100–500 mg/kg), administered orally to mice 7 to 21 days after bleomycin-induced lung injury, dose-dependently reduces interstitial fibrotic collagen deposition caused by bleomycin and blocks Smad3 phosphorylation [2].
AliasPLN-74809
Chemical Properties
Molecular Weight492.61
FormulaC27H36N6O3
Cas No.2376257-44-0
SmilesN([C@@H](CCN(CCCCC=1NC=2C(=CC1)CCCN2)CCOC)C(O)=O)C=3C4=C(N=CN3)C=CC=C4
Storage & Solubility Information
Storagekeep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (202.83 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0300 mL10.1500 mL20.3000 mL101.5002 mL
5 mM0.4060 mL2.0300 mL4.0600 mL20.3000 mL
10 mM0.2030 mL1.0150 mL2.0300 mL10.1500 mL
20 mM0.1015 mL0.5075 mL1.0150 mL5.0750 mL
50 mM0.0406 mL0.2030 mL0.4060 mL2.0300 mL
100 mM0.0203 mL0.1015 mL0.2030 mL1.0150 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Bexotegrast | purchase Bexotegrast | Bexotegrast cost | order Bexotegrast | Bexotegrast chemical structure | Bexotegrast in vivo | Bexotegrast in vitro | Bexotegrast formula | Bexotegrast molecular weight